National Health Service
Richmond House
79 Whitehall
London
SW1A 2NS
United Kingdom
Tel: 44-207-210-4850
Fax: 44-207-270-5244
40 articles about National Health Service
-
Vertex Pharmaceuticals (MA) Release: National Health Service in England Funds KALYDECO (ivacaftor), the First Medicine to Treat the Underlying Cause of Cystic Fibrosis, for People With a Specific Genetic Mutation (G551D)
12/19/2012
-
Becton, Dickinson and Company Announces Award to National Health Service Supply Chain Framework Agreement
12/14/2012
-
Becton, Dickinson and Company Announces Award to National Health Service Supply Chain Framework Agreement
12/10/2012
-
Spiracur Awarded National Health Service Supply Chain Framework Agreement and Drug Tariff Approval in England and Wales for SNaP Wound Care System
9/5/2012
-
National Health Service Chief Warns Over National Institute for Clinical Excellence (NICE) Drug Blacklists
8/14/2012
-
GlaxoSmithKline, UCB, Inc. and Eisai Inc. in Unique National Health Service Joint Working Pact
6/29/2012
-
National Health Service Recommends Assessment for Elevated Protease Activity Using Diagnostic Test to Help Decide Venous Leg Ulcers Treatment Pathway, Reports Systagenix
3/5/2012
-
BioIndustry Association and EMIG to Explore Impact of National Health Service Reforms on Industry
2/9/2012
-
National Health Service Publishes Implementation Guidelines for Source BioScience's Automated Cervical Cancer Screening Technology
12/19/2011
-
Source BioScience Receives National Health Service Approval for Automated Cervical Cancer Screening Technology
7/13/2011
-
DNA Genotek's Oragene(R).DNA Enables Large Sample Collection Project at the U.K.'s Wellcome Trust Sanger Institute and the National Health Service
6/28/2011
-
Drink Causes 10% of Cancer in Men and Even the Odd Glass Isn't Safe, National Health Service Study
4/8/2011
-
Pierre Fabre's Bladder Cancer Drug, Javlor too Costly for National Health Service, National Institute for Clinical Excellence (NICE) Says
11/23/2010
-
Self-diagnosis Saves National Health Service £44 Million a Year
11/11/2010
-
Datamonitor Report: National Health Service Faces a Funding Shortfall of £42 Billion and Expert Comment on CSR Impacts to Healthcare and Pharma
10/21/2010
-
Reckitt Benckiser Plc Fined $16.4 Million by U.K. Regulator Over Hearturn Drug Supplies to the National Health Service
10/15/2010
-
BioNeutral Group Collaborating with Steri-7 (TM) on Product Distribution
6/16/2010
-
Scottish Medicines Consortium Accepts Abraxis BioScience, Inc.'s ABRAXANE(R) for Use within National Health Service for Scotland
4/13/2010
-
Celgene International Sárl: REVLIMID(R) Receives Positive Final Appraisal Determination from National Institute for Clinical Excellence (NICE) for Use in the National Health Service in England and Wales
4/23/2009
-
Celgene International Sárl Release: REVLIMID(R) Receives Preliminary Positive Recommendation from National Institute for Clinical Excellence (NICE) And National Health Service in England and Wales
1/30/2009